Chlorpromazine oligomer is a potentially active substance that inhibits human D-amino acid oxidase, product of a susceptibility gene for schizophrenia

References

• K Fukui, F Watanabe, T Shibata, and Y Miyake. (1987). Molecular cloning and sequence analysis of cDNAs encoding porcine kidney D-amino acid oxidase. Biochemistry 26:3612–3618.
   PubMed Web of Science ®Google Scholar
• K Momoi, K Fukui, F Watanabe, and Y Miyake. (1988). Molecular cloning and sequence analysis of cDNA encoding human kidney D-amino acid oxidase. FEBS Lett 238:180–184.
   PubMed Web of Science ®Google Scholar
• K Fukui, K Momoi, F Watanabe, and Y Miyake. (1988). In vivo and in vitro expression of porcine D-amino acid oxidase: In vitro system for the synthesis of a functional enzyme. Biochemistry 27:6693–6697.
   PubMedGoogle Scholar
• K Fukui, and Y Miyake. (1992). Molecular cloning and chromosomal localization of a human gene encoding D-amino-acid oxidase. J Biol Chem 267:18631–18638.
   PubMed Web of Science ®Google Scholar
• Y Urai, O Jinnouchi, KT Kwak, A Suzue, S Nagahiro, and K Fukui. (2002). Gene expression of D-amino acid oxidase in cultured rat astrocytes: Regional and cell type specific expression. Neurosci Lett 324:101–104.
   PubMedGoogle Scholar
• HK Park, Y Shishido, S Ichise-Shishido, T Kawazoe, K Ono, S Iwana, Y Tomita, K Yorita, T Sakai, and K Fukui. (2006). Potential role for astroglial D-amino acid oxidase in extracellular D-serine metabolism and cytotoxicity. J Biochem (Tokyo) 139:295–304.
   PubMedGoogle Scholar
• A Sawa, and SH Snyder. (2002). Schizophrenia: Diverse approaches to a complex disease. Science 296:692–695.
   PubMed Web of Science ®Google Scholar
• I Chumakov, M Blumenfeld, O Guerassimenko, L Cavarec, M Palicio, H Abderrahim, L Bougueleret, C Barry, H Tanaka, P La Rosa, and et al (2002). Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 99:13675–13680.
   PubMed Web of Science ®Google Scholar
• K Yagi, T Nagatsu, and T Ozawa. (1956). Inhibitory action of chlorpromazine on the oxidation of D-amino-acid in the diencephalon part of the brain. Nature 177:891–892.
   PubMedGoogle Scholar
• PKF Yeung, JW Hubbard, JK Cooper, and KK Midha. (1983). A study of the kinetics of chlorpromazine sulfoxide by a specific radioimmunoassay after a single oral dose of chlorpromazine in healthy volunteers. J Pharmacol Exp Ther 226:833–838.
   PubMed Web of Science ®Google Scholar
• EGC Clarke, editor. An extra pharmacopoeia companion volume: Isolation and identification of drugs in pharmaceuticals, body fluids and post-mortem materialLondon: Pharmaceutical Press; (1969). p 256–257.
   Google Scholar
• B Ljunggren. (1977). Phenothiazine phototoxicity: Toxic chlorpromazine photoproducts. J Invest Dermatol 69:383–386.
   PubMed Web of Science ®Google Scholar
• J Menz, SA Muller, and SM Connolly. (1988). Photopatch testing: A six-year experience. J Am Acad Dermatol 18:1044–1047.
   PubMed Web of Science ®Google Scholar
• CF Chignell, AG Motten, and GR Buettner. (1985). Photoinduced free radicals from chlorpromazine and related phenothiazines: Relationship to phenothiazine-induced photosensitization. Environ Health Perspect 64:103–110.
   PubMed Web of Science ®Google Scholar
• M Wollemann, and P Elödi. (1961). Die Hemmung der kristallisierten D-glyceraldehyd-3-phosphat dehydrogenase aktivität durch phenothiazine und aminoketone. [Inhibition of crystallized D-glyceraldehyde-3-phosphate dehydrogenase activity by phenothiazine and aminoketone.]. Biochem Pharmacol 6:228–232.
   PubMedGoogle Scholar
• T Akera, and TM Brody. (1972). Effects of chlorpromazine free radical on brain microsomal enzymes. Biochem Pharmacol 21:1403–1411.
   PubMedGoogle Scholar
• S Muraoka, and T Miura. (2003). Inactivation of cholinesterase induced by chlorpromazine cation radicals. Pharmacol Toxicol 92:100–104.
   PubMedGoogle Scholar
• LH Piette, G Bulow, and I Yamazaki. (1964). Electron-paramagnetic-resonance studies of the chlorpromazine free radical formed during enzymic oxidation by peroxidase-hydrogen peroxide. Biochim Biophys Acta 88:120–129.
   PubMedGoogle Scholar
• B Ljunggren, and H Möller. (1977). Phenothiazine phototoxicity: An experimental study on chlorpromazine and its metabolites. J Invest Dermatol 68:313–317.
   PubMed Web of Science ®Google Scholar
• DJ Cavanaugh. (1957). Oxidation of chlorpromazine by peroxidase and catalase. Science 125:1040–1041.
   PubMed Web of Science ®Google Scholar
• MH Van Woert. (1968). Isolation of chlorpromazine pigments in man. Nature 219:1054–1056.
   PubMedGoogle Scholar
• CL Huang. (1967). Isolation and identification of urinary chlorpromazine metabolites in man. Int J Neuropharmacol 6:1–13.
   PubMedGoogle Scholar
• IS Forrest, FM Forrest, and M Berger. (1958). Free radicals as metabolites of drugs derived from phenothiazine. Biochim Biophys Acta 29:441–442.
   PubMedGoogle Scholar
• T Kawazoe, H Tsuge, MS Pilone, and K Fukui. (2006). Crystal structure of human D-amino acid oxidase: Context-dependent variability of the backbone conformation of the VAAGL hydrophobic stretch located at the si-face of the flavin ring. Protein Sci 15:2708–2717.
   PubMed Web of Science ®Google Scholar
• V Massey, and B Curti. (1966). A new method of preparation of D-amino acid oxidase apoprotein and a conformational change after its combination with flavin adenine dinucleotide. J Biol Chem 241:3417–3423.
   PubMed Web of Science ®Google Scholar
• AA Raibekas, K Fukui, and V Massey. (2000). Design and properties of human D-amino acid oxidase with covalently attached flavin. Proc Natl Acad Sci USA 97:3089–3093.
   PubMedGoogle Scholar
• G Molla, S Sacchi, M Bernasconi, MS Pilone, K Fukui, and L Pollegioni. (2006). Characterization of human D-amino acid oxidase. FEBS Lett 580:2358–2364.
   PubMed Web of Science ®Google Scholar
• C Setoyama, Y Nishina, H Tamaoki, H Mizutani, I Miyahara, K Hirotsu, K Shiga, and R Miura. (2002). Effects of hydrogen bonds in association with flavin and substrate in flavoenzyme D-amino acid oxidase. The catalytic and structural roles of Gly313 and Thr317. J Biochem (Tokyo) 131:59–69.
   PubMedGoogle Scholar
• M Miyano, K Fukui, F Watanabe, S Takahashi, M Tada, M Kanashiro, and Y Miyake. (1991). Studies on Phe-228 and Leu-307 recombinant mutants of porcine kidney D-amino acid oxidase: Expression, purification, and characterization. J Biochem (Tokyo) 109:171–177.
   PubMedGoogle Scholar
• K Yagi, T Ozawa, and T Nagatsu. (1960). Mechanism of inhibition of D-amino acid oxidase. IV. Inhibitory action of chlorpromazine. Biochim Biophys Acta 43:310–317.
   PubMed Web of Science ®Google Scholar
• S Gabay, and SR Harris. (1967). Studies of flavin-adenine dinucleotide-requiring enzymes and phenothiazines. 3. Inhibition kinetics with highly purified D-amino acid oxidase. Biochem Pharmacol 16:803–812.
   PubMed Web of Science ®Google Scholar
• S Gabay, and SR Harris. (1965). Studies of flavin adenine dinucleotide-requiring enzymes and phenothiazines-I. Interactions of chlorpromazine and D-amino acid oxidase. Biochem Pharmacol 14:17–26.
   PubMed Web of Science ®Google Scholar
• A Vázquez, J Tudela, R Varón, and F García-Cánovas. (1992). Determination of the molar absorptivities of phenothiazine cation radicals generated by oxidation with hydrogen peroxide/peroxidase. Anal Biochem 202:245–248.
   PubMed Web of Science ®Google Scholar
• M Carlsson, and A Carlsson. (1990). Interactions between glutamatergic and monoaminergic systems within the basal ganglia–implications for schizophrenia and Parkinson's disease. Trends Neurosci 13:272–276.
   PubMed Web of Science ®Google Scholar
• JT Coyle. (1996). The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry 3:241–253.
   PubMed Web of Science ®Google Scholar
• G Tsai, P Yang, LC Chung, N Lange, and JT Coyle. (1998). D-Serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 44:1081–1089.
   PubMed Web of Science ®Google Scholar
• BK Yamamoto, and MA Cooperman. (1994). Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J Neurosci 14:4159–4166.
   PubMed Web of Science ®Google Scholar
• PE Brandish, CS Chiu, J Schneeweis, NJ Brandon, CL Leech, O Kornienko, EM Scolnick, B Strulovici, and W Zheng. (2006). A cell-based ultra-high-throughput screening assay for identifying inhibitors of D-amino acid oxidase. J Biomol Screen 11:481–487.
   PubMedGoogle Scholar
• J Pinto, YP Huang, and RS Rivlin. (1981). Inhibition of riboflavin metabolism in rat tissues by chlorpromazine, imipramine, and amitriptyline. J Clin Invest 67:1500–1506.
   PubMed Web of Science ®Google Scholar
• CL Huang, and FL Sands. (1967). Effect of ultraviolet irradiation on chlorpromazine. II. Anaerobic condition. J Pharm Sci 56:259–264.
   PubMed Web of Science ®Google Scholar
• GP Sgaragli, R Ninci, L Della Corte, M Valoti, M Nardini, V Andreoli, and G Moneti. (1986). Promazine: A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics. Drug Metab Dispos 14:263–266.
   PubMed Web of Science ®Google Scholar
• Y Mizuno, K Sato, T Sano, R Kurihara, T Kojima, Y Yamakawa, A Ishii, and Y Katsumata. (2002). Identification and characterization of 17 phenothiazine compounds by capillary high-performance liquid chromatography/fast atom bombardment mass spectrometry. Leg Med (Tokyo) 4:207–216.
   PubMedGoogle Scholar
• GP Sgaragli, M Valoti, M Palmi, M Frosini, MG Giovannini, L Bianchi, and L Della Corte. (1995). Rat tissue concentrations of chlorimipramine, chlorpromazine and their N-demethylated metabolites after a single oral dose of the parent compounds. J Pharm Pharmacol 47:782–790.
   PubMed Web of Science ®Google Scholar
• S Sato, and A Koshiro. (1995). Pharmacokinetic analysis of chlorpromazine in rat serum, cerebrospinal fluid and striatum. Biol Pharm Bull 18:593–599.
   PubMed Web of Science ®Google Scholar
• E Wajnberg, M Tabak, PA Nussenzveig, CMB Lopes, and SRW Louro. (1988). pH-dependent phase transition of chlorpromazine micellar solutions in the physiological range. Biochim Biophys Acta 944:185–190.
   PubMedGoogle Scholar